Pharma Aids Limited announcements
270 Dhaka Stock Exchange announcements for Pharma Aids Limited (PHARMAID) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2014 (14).
- Credit Rating
National Credit Ratings Limited (NCR) has announced the rating of the Company as BBB+ in the long term and ST-3 in the short term based on audited financial statements of the Company up to June 30, 2014.
- trade resume
Normal trading of the shares of the Company will resume on 03.12.2014 after record date.
- will remain suspended
Trading of the shares of the Company will remain suspended on record date i.e., 02.12.2014.<br>
- trade suspension
Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 30.11.2014 to 01.12.2014. Trading of the shares of the Company will remain suspended on record date i.e., 02.12.2014.
- Q1 Earning
As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2014 (July'14 to Sep'14), the Company has reported net profit after tax of Tk. 7.71 million with EPS of Tk. 2.47 as against Tk. 2.74 million and Tk. 0.88 respectively for the same period of the previous year. <div id="__if72ru4sdfsdfruh7fewui_once" style="display:none;"></div> <div id="__hggasdgjhsagd_once" style="display:none;"></div>
- dividend
The Board of Directors has recommended 25% cash dividend for the year ended on June 30, 2014. Date of AGM: 28.12.2014, Time: 11:00 AM, Venue: Kendrio Kanchi-Kancher Mela Auditorium, 37/A Segun Bagicha, Dhaka-1000. Record Date: 02.12.2014. The Company has also reported net profit after tax of Tk. 17.39 Million, EPS of Tk. 5.58, NAV per share of Tk. 31.76 and NOCFPS of Tk. 0.55 for the year ended on June 30, 2014.
- no price limit
There will be no price limit on the trading of the shares of the Company today (13.11.2014) following its corporate declaration.
- Board Meeting
As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2014 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2014.
- assets import
The Company has informed that the Board of Directors of the Company has decided to import following assets immediately: (1) Spare Parts for Ampoule Manufacturing Machine @ Tk. 20.00 Lacs (approx.) and (2) PSA Oxygen Generator (Oxygen Gas Producer) with standard accessories @ Tk. 55.00 Lacs (approx.).
- Trading of shares of Pharma Aids Ltd. will resume today (11.05.2014) as the Company has complied with relevant provision
Trading of shares of Pharma Aids Ltd. will resume today (11.05.2014) as the Company has complied with relevant provisions of Listing Regulations of the Dhaka Stock Exchange Limited.
- (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st March 2014 (Jan'14 to March'14), the Compan
(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st March 2014 (Jan'14 to March'14), the Company has reported net profit/(loss) after tax of Tk. 4.19 million with EPS of Tk. 1.34 as against Tk. (2.83) million and Tk. (0.91) respectively for the same period of the previous year. Whereas net profit after tax was Tk. 10.82 million with EPS of Tk. 3.47 for the period of nine months (July'13 to March'14) ended on 31.03.2014 as against Tk. 3.04 million and Tk. 0.97 respectively for the same period of the previous year.
- Trading of shares of the Company has been suspended with effect from today (February 05, 2014) and shall remain suspende
Trading of shares of the Company has been suspended with effect from today (February 05, 2014) and shall remain suspended until further notice as the Company has created impediments for DSE in carrying out its normal activities in relation to listed Companies through not allowing DSE official to conduct an official factory premise inspection. The issuer has failed to comply with its continuing obligations in respect of listing regulations by preventing the Exchange from carrying out its essential work to protect the greater interest of investors. A show-cause notice has also been served upon the Company by the Exchange to clarify their position in this regard.
- H/Y Earnings
As per un-audited half yearly accounts as on 31.12.2013 (July'13 to Dec'13), the Company has reported net profit after tax of Tk. 6.63 million with EPS of Tk. 2.13 as against Tk. 4.99 million and Tk. 1.60 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 3.89 million with EPS of Tk. 1.25 for the period of 3 months (Oct'13 to Dec'13) ended on 31.12.2013 as against Tk. 1.03 million and Tk. 0.33 respectively for the same period of the previous year.
- (H/Y): As per un-audited half yearly accounts as on 31.12.2013 (July'13 to Dec'13), the Company has reported net profit
(H/Y): As per un-audited half yearly accounts as on 31.12.2013 (July'13 to Dec'13), the Company has reported net profit after tax of Tk. 6.63 million with EPS of Tk. 2.13 as against Tk. 4.99 million and Tk. 1.60 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 3.89 million with EPS of Tk. 1.25 for the period of 3 months (Oct'13 to Dec'13) ended on 31.12.2013 as against Tk. 1.03 million and Tk. 0.33 respectively for the same period of the previous year.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.